
Akums Drugs & Pharmaceuticals Share Price
₹518.25 +10.45 (2.06%)
18 Mar, 2025 16:06
Start SIP in
AKUMS
Performance
- Low
- ₹506
- High
- ₹523
- 52 Week Low
- ₹433
- 52 Week High
- ₹1,176
- Open Price₹506
- Previous Close₹508
- Volume200,362
Investment Returns
- Over 1 Month + 0.39%
- Over 3 Month -10.49%
- Over 6 Month -39.41%
- Over 1 Year -23.68%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 54.7
- PEG Ratio
- -
- Market Cap Cr
- 8,157
- P/B Ratio
- 2.9
- Average True Range
- 27.44
- EPS
- 9.08
- Dividend Yield
- 0
- MACD Signal
- -18.16
- RSI
- 46.95
- MFI
- 56.13
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹518.25
+
10.45
(2.06%)

-
- Bearish Moving Average 6
-
- Bullish Moving Average 8
- 20 Day
- ₹509.50
- 50 Day
- ₹547.17
- 100 Day
- ₹626.65
- 200 Day
- -
Resistance and Support
510.67
- R3 529.93
- R2 524.47
- R1 516.13
- S1 502.33
- S2 496.87
- S3 488.53
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-06 | Quarterly Results | |
2024-11-09 | Quarterly Results | |
2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹518 As on 18 March, 2025 | 15:52
The Market Cap of Akums Drugs & Pharmaceuticals is ₹8156.9 Cr As on 18 March, 2025 | 15:52
The P/E ratio of Akums Drugs & Pharmaceuticals is 54.7 As on 18 March, 2025 | 15:52
The PB ratio of Akums Drugs & Pharmaceuticals is 2.9 As on 18 March, 2025 | 15:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.